# Archscope Identity P1 Manual Review

## Scope

Phase P1: First-Read Docs Identity Convergence.

Reviewed files:

- `README.md`
- `docs/getting-started.md`
- `docs/cli-reference.md`
- `docs/architecture-testing.md`
- `docs/README.md`
- `docs/plans/2026-05-01-feat-archscope-identity-convergence-and-rename-readiness-plan.md`

## Simplify Pass

Status: pass.

Findings:

- No product-document wording change is required for P1. The first-read docs
  already present Archscope as the active product identity.
- Compatibility references remain localized to package, repository, command
  alias, and artifact-path facts. Rewriting them would add churn and risk
  implying unsupported package or artifact namespace renames.
- Historical and migration context remains behind maintainer or compatibility
  framing and does not need first-read rewriting.

## HE Code Review Pass

Status: pass.

Findings:

- SA2, SA3, SA9, and SA10 are satisfied for first-read docs: Archscope is the
  user-facing product name, and compatibility names are labelled as package,
  repository, alias, or path facts.
- No hard package rename, repository rename, `.diagram` rename, or `.diagramrc`
  rename is implied.
- The remaining `diagram` usage in the first-read set is compatibility-scoped,
  including the `diagram validate .` example under the compatibility command
  note in `docs/getting-started.md`.

## Validation

- Command: `vale --config .vale.ini README.md docs/getting-started.md docs/cli-reference.md docs/architecture-testing.md docs/README.md` -> pass (0 errors, 0 warnings, 0 suggestions).
- Command: `npm run docs:style:changed` -> pass (`No staged documentation changes detected for Vale`).
- Command: `rg -n "diagram-cli is|diagram generator|Mermaid generator|agent memory artifact system|architecture governance framework" README.md docs/getting-started.md docs/cli-reference.md docs/architecture-testing.md docs/README.md` -> pass (no matches).

## Verdict

P1 is complete with no blocking findings.

WROTE: artifacts/reviews/archscope-identity-p1-manual-review.md
